Moderate riskFDA DrugClass II

Baxter Vasopressin injection recalled for manufacturing quality deviations

Baxter Healthcare Corporation is recalling three lots of Vasopressin injection due to manufacturing process deviations that do not meet FDA quality standards. The affected lots were distributed nationwide, in Puerto Rico, and Chile. No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Baxter recalls

What to do

  1. Check if your facility has received any of the three affected lots (NC185448, NC192910, or NC195218)
  2. Contact Baxter Healthcare or the FDA if you have questions about this recall

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-9647-12.
Sold in
Nationwide
Made for
Adults

This recall covers 17 products — see all of them.

Details

Units affected
N/A
Illnesses reported
None reported
Manufactured in
1 Baxter Pkwy, N/A, Deerfield, IL, United States
Classification
Class II
Recall number
D-0819-2026

In the FDA's words

Description
Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-9647-12. CGMP Deviations Lot # NC185448, Exp Date: 8/31/2027; Lot # NC192910, Exp Date: 4/30/2028; Lot # NC195218, Exp Date: 6/30/2028. Distribution: US Nationwide; Puerto Rico; and Chile. Affected quantity: N/A
Hazard
CGMP Deviations

17 products in this recall

Baxter IV drug bags recalled for manufacturing quality issues

Baxter is recalling 17 intravenous (IV) drug products for manufacturing quality problems, called CGMP deviations, which are lapses in the required production standards. The products include vancomycin, daptomycin, clindamycin, famotidine, dexmedetomidine, vasopressin, pantoprazole, insulin, nicardipine, and amiodarone, plus the brand names Myxredlin, CARDENE IV, and Nexterone. They were distributed nationwide, in Puerto Rico, and in Chile, and no injuries have been reported.

The agency lists each product separately. Check every one you might have.

More from Baxter

See all

Related topics

OtherDrugsSold nationwideMore from FDA Drug